Related Experiment Video

Updated: May 22, 2026

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
05:32

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection

Published on: September 21, 2015

Rifaximin for the prevention of spontaneous bacterial peritonitis

Georgios N Kalambokis, Athanasia Mouzaki, Maria Rodi

    World Journal of Gastroenterology
    |April 25, 2012
    PubMed

    Insights

    Rifaximin significantly reduces spontaneous bacterial peritonitis (SBP) risk in cirrhotic patients by lowering ascitic neutrophils and endotoxin levels. This offers a promising alternative to long-term norfloxacin prophylaxis, mitigating quinolone resistance concerns.

    Area of Science:

    • Gastroenterology and Hepatology
    • Infectious Diseases
    • Microbiology

    Background:

    • Spontaneous bacterial peritonitis (SBP) is a serious complication in cirrhotic patients.
    • Norfloxacin prophylaxis for SBP is associated with the development of quinolone-resistant bacteria.
    • Alternative prophylactic agents are needed to improve patient outcomes and reduce antibiotic resistance.

    Discussion:

    • This study investigated the efficacy of rifaximin in preventing SBP in cirrhotic patients.
    • Rifaximin treatment led to a significant reduction in ascitic neutrophil count and plasma endotoxin levels.
    • These findings suggest rifaximin's potential as a safe and effective prophylactic agent.

    Key Insights:

    • A 4-week regimen of rifaximin (1200 mg/day) significantly decreased ascitic neutrophil counts in cirrhotic patients.
    • Rifaximin administration resulted in a significant reduction in plasma endotoxin levels.
    • Long-term rifaximin use was associated with a reduced 5-year probability of SBP.

    Outlook:

    • Rifaximin represents a promising alternative for SBP prophylaxis in cirrhotic patients.
    • Further research should explore long-term safety and efficacy across diverse patient populations.
    • This approach may help combat the rising issue of antibiotic resistance in clinical practice.
    Keywords:
    AscitesCirrhosisRifaximinSpontaneous bacterial peritonitis

    More Related Videos

    Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis06:45

    Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis

    Published on: December 18, 2010

    Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

    Assay Development for High-Throughput Drug Screening Against Mycobacteria

    Published on: October 25, 2024

    Related Concept Videos

    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
    Drugs for Treatment of Diarrhea-Predominant IBS01:17

    Drugs for Treatment of Diarrhea-Predominant IBS

    Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
    Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
    Inflammatory Bowel Disease IV: Pharmacological Management01:29

    Inflammatory Bowel Disease IV: Pharmacological Management

    Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
    Pharmacologic...
    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

    Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

    A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...